I just invited you to earn with Uber. Earn at least $1,374 for your first 151 passenger trips in 30 days. 🤑 💲💲💲💲💲🤑💵💵💵💵💵 🎉🎉🎉 #job #sidegig #gigoftheday #WONDERING

I just invited you to earn with Uber. Earn at least $2,040 for your first 179 passenger trips in 30 days.

@BiotechInvqgt0 Not at the moment, but they will surely seek better financing terms. For now, they have a 12-month runway, according to what management mentioned in the last conference call.

$HUMA Humacyte doesn’t need more cash? https://t.co/di5z3kWNK8

Humacyte’s ATEV Evaluated After Long-Term Clinical Use | @humacyte https://t.co/N9vcKaeVnI

@elonmusk Elon can you invest in a stock called humacyte ?

$HUMA BTIG Humacyte, Inc. (HUMA) Buy, $6 PT Takeaways from VEITH KOL Event; Feedback Remains Encouraging What You Should Know: We attended HUMA's ATEV Interactive Program at the Vascular And Endovascular Issues, Techniques and Horizons (VEITH) Symposium in New York where

$HUMA [1.19$] [6.22%] [November 21, 2025] Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results

@jrouldz Recellularizatuon! Waiting on a big military contract

#Humacyte is revolutionizing the treatment of vascular and organ-related diseases by developing and manufacturing implantable, bioengineered human tissues Their Stock is currently trading at $1.26 And I believe this is an insane buying opportunity Price Target $10 $HUMA

BREAKING: White House announces it has eliminated the Department of Government Efficiency, in apparent cost-saving measure.

A new study in APA finds that heavy use of TikTok and Instagram’s, $META, videos may “rot” the brain cognitively. Researchers reported that frequent exposure is associated with weaker attention spans, poorer cognitive performance, and lower overall life satisfaction.

BREAKING: U.S. unemployment rate blows past expectations, soaring to the highest level in years.

$Huma - Insider buying - 622K total Shares even more bullish on this company just bought another 10,000 shares at $1.14 - $10 coming 🔜 #Humacyte

The @VEITHsymposium 2025 is packed with education! If you would like to learn more about Humacyte’s Acellular Tissue Engineered Vessel, you won’t want to miss any of the 6 presentations on Wednesday and Thursday! Wednesday, Nov 19th : Podium Session 5 on Concourse A, Concourse

@humacyte @biotech Now sell for $15k a vessel, become the go-to conduit and then increase over a 3y period to $25k

StubHub stock plummets 24% after company withholds fourth-quarter guidance

Tariffs are acting as a substantial drag on growth and are actively contributing to persistent inflation, eroding real income gains for consumers.

The US shutdown led to roughly 60,000 job losses outside the federal workforce, cost the economy about $15 billion each week for a total of around $92 billion, and could reduce fourth-quarter GDP by as much as 1.5 percentage points, per Kevin Hassett.

In a recent press release, Humacyte shared there positive two-year data results from the Phase 3 Dialysis Access trial presented at the American Society of Nephrology’s Kidney Week 2025. Thank you to the clinical team and the society for a great educational event! For more

🚨 OpenAI is requesting the government guarantee financing for chip deals wtf? pre-arranged bailouts?? wtf is going on